First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation

• DOI: 10.1016/j.diagmicrobio.2008.06.012
• Publication Date: 2008-08-13T21:34:09Z
• Authors: Jutta Auberger; Cornelia Lass-Flörl; Johannes Clausen; Romuald Bellmann; Walter Buzina; Günther Gastl; David Nachbaur
• Keywords: 0303 health sciences; Antifungal Agents; Lung Diseases, Fungal; Hematopoietic Stem Cell Transplantation; Triazoles; 3. Good health; Young Adult; 03 medical and health sciences; Aspergillus; Fanconi Anemia; Fatal Outcome; Pyrimidines; Drug Resistance, Fungal; Amphotericin B; Aspergillosis; Humans; Transplantation, Homologous; Female; Voriconazole; Bronchoalveolar Lavage Fluid

Aspergillus niveus is a species uncommon in clinical samples, and to date, invasive fungal infections caused by this fungal pathogen have not been described. This is the 1st report on a pulmonary breakthrough aspergillosis caused by A. niveus in a 21-year-old woman after allogeneic hematopoietic stem cell transplantation for Fanconi anemia.